Syndax Pharmaceuticals SNDX Stock Issued During Period, Value, Stock Options Exercised
Stock Issued During Period, Value, Stock Options Exercised at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's stock issued during period, value, stock options exercised.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's stock issued during period, value, stock options exercised?
- Syndax Pharmaceuticals (SNDX) reported stock issued during period, value, stock options exercised of $7.46M in Q1 2026.
- How has Syndax Pharmaceuticals's stock issued during period, value, stock options exercised changed year-over-year?
- Syndax Pharmaceuticals's stock issued during period, value, stock options exercised increased by 1837.7% year-over-year, from $385K to $7.46M.